Cytosorbents

(NASDAQ) CTSO

Current Price$0.47

Market Cap$28.82M

Since IPO (2006)-99%

5 Year-94%

1 Year-56%

1 Month-19%

Cytosorbents Financials at a Glance

Market Cap

$28.82M

Revenue (TTM)

$37.20M

Net Income (TTM)

-$11.85M

EPS (TTM)

-$0.19

P/E Ratio

-2.41

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$0.47

Volume

140

Open

$0.48

Price

$0.47

Volume

140

Open

$0.48

Previous Close

$0.47

Daily Range

$0.47 - $0.48

52-Week Range

$0.44 - $1.39

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$0.47

Volume

140

Open

$0.48

Previous Close

$0.47

Daily Range

$0.47 - $0.48

52-Week Range

$0.44 - $1.39

Estimated Earnings Date

Aug 6, 2026

CTSO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cytosorbents

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

129

CEO

Phillip P. Chan, MD, PhD

Website

cytosorbents.com

Headquarters

Princeton, NJ 08540, US

CTSO Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

-36%

Net Income Margin

-32%

Return on Equity

-142%

Return on Capital

-55%

Return on Assets

-29%

Earnings Yield

-41.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$28.82M

Shares Outstanding

62.79M

Volume

140

Avg. Volume

110.43K

Financials (TTM)

Gross Profit

$26.49M

Operating Income

-$14.24M

EBITDA

-$4.36M

Operating Cash Flow

-$12.38M

Capital Expenditure

-$164.00K

Free Cash Flow

-$12.54M

Cash & ST Invst.

$6.25M

Total Debt

$29.11M

Cytosorbents Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$8.86M

+1.6%

Gross Profit

$6.13M

-1.3%

Gross Margin

69.16%

N/A

Market Cap

$28.82M

N/A

Market Cap/Employee

$193.44K

N/A

Employees

149

N/A

Net Income

-$5.13M

-246.9%

EBITDA

-$3.04M

-549.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$14.15M

+8.1%

Accounts Receivable

$7.15M

-6.8%

Inventory

$4.48M

+48.5%

Long Term Debt

$11.75M

-55.7%

Short Term Debt

$7.21M

+1421.7%

Return on Assets

-29.21%

N/A

Return on Invested Capital

-55.22%

N/A

Free Cash Flow

-$1.17M

+66.6%

Operating Cash Flow

-$1.16M

+66.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NMTCNeuroOne Medical Technologies Corporation

NMTCNeuroOne Medical Technologies Corporation$3.44-1.15%

TELATELA Bio, Inc.

TELATELA Bio, Inc.$0.88-0.10%

TELOTelomir Pharmaceuticals, Inc. Common Stock

TELOTelomir Pharmaceuticals, Inc. Common Stock$1.21-4.72%

SRTSSensus Healthcare, Inc.

SRTSSensus Healthcare, Inc.$2.70-4.26%

ICCMIceCure Medical Ltd

ICCMIceCure Medical Ltd$4.37-15.57%

BDMDBaird Medical Investment Holdings Limited

BDMDBaird Medical Investment Holdings Limited$1.26-7.35%

MDAISpectral AI, Inc.

MDAISpectral AI, Inc.$1.89-5.97%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

Questions About CTSO

What is the current price of Cytosorbents?

Cytosorbents is trading at $0.47 per share.

What is the 52-week range for Cytosorbents?

Over the past 52 weeks, Cytosorbents has traded between $0.44 and $1.39.

How much debt does Cytosorbents have?

As of the most recent reporting period, Cytosorbents reported total debt of $29.54M.

How much cash does Cytosorbents have on hand?

Cytosorbents reported $4.81M in cash and cash equivalents in its most recent financial results.

What is Cytosorbents’s dividend yield?

Cytosorbents does not currently have a dividend yield.

Cytosorbents

Cytosorbents Financials at a Glance

CTSO News

Here's Why Cytosorbents Is Up 17% Today

Why CytoSorbents Is Soaring 12% Today

Why CytoSorbents Stock Got Clobbered Today

Why Cytosorbents Corp Shares Burst Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cytosorbents

CTSO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cytosorbents Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CTSO

What is the current price of Cytosorbents?

What is the 52-week range for Cytosorbents?

How much debt does Cytosorbents have?

How much cash does Cytosorbents have on hand?

What is Cytosorbents’s dividend yield?

Premium Investing Services